Phentermine-topiramate extended-release capsules (Qsymia®) have not been requested for formulary status and are not routinely stocked by sites due to the REMS program. The goal of the Qsymia REMS is to mitigate the risk of embryo-fetal toxicity, and includes pharmacy and wholesaler-distributor requirements for dispensing. See Legacy Health REMS Requirements for detail.
Add Formweb to your mobile device
Phentermine-topiramate extended-release capsules (Qsymia®) have not been requested for formulary status and are not routinely stocked by sites due to the REMS program. The goal of the Qsymia REMS is to mitigate the risk of embryo-fetal toxicity, and includes pharmacy and wholesaler-distributor requirements for dispensing. See Legacy Health REMS Requirements for detail.